Summit Therapeutics
SMMT
SMMT
93 hedge funds and large institutions have $60.4M invested in Summit Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 15 closing their positions.
Holders
93
Holders Change
-7
Holders Change %
-7%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
34
Reduced
22
Closed
15
Calls
$2.1M
Puts
$165K
Net Calls
+$1.93M
Net Calls Change
+$1.99M
Top Buyers
1 |
1
Charles Schwab
San Francisco,
California
|
$1.76M |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$5.53M |
3 |
3
BlackRock
New York
|
$16.8M |
4 |
4
Barclays
London,
United Kingdom
|
$277K |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$400K |